Supply Ability | 10000 Kit/Kit per Day |
Delivery Time | To be negotiated |
Packaging Details | Kit |
Product name | 2019 NCoV Coronavirus Neutralizing Antibody Rapid Test Immunochromatography Adopts |
Composition | Detection card, sample buffer |
Storage conditions | 2℃~30℃ |
term of validity | 12 months |
Sample requirements | Serum, plasma or whole blood |
Brand Name | ZOSBIO |
Model Number | 2019-NCoV Neutralizing Antibody |
Certification | CE BfArm |
Place of Origin | Henan,China |
View Detail Information
Explore similar products
BetaCoronavirus Sars-Cov-2 Neutralization Antibody Test Immunochromatography
ZOSBIO Coronavirus Neutralizing Antibody Rapid Test 1Test/Kit To 100Tests/Kit
ZOSBIO 2019-Ncov Neutralization Antibody Test Kit
SARS-CoV-2 Coronavirus Neutralizing Antibody Rapid Test
Product Specification
Supply Ability | 10000 Kit/Kit per Day | Delivery Time | To be negotiated |
Packaging Details | Kit | Product name | 2019 NCoV Coronavirus Neutralizing Antibody Rapid Test Immunochromatography Adopts |
Composition | Detection card, sample buffer | Storage conditions | 2℃~30℃ |
term of validity | 12 months | Sample requirements | Serum, plasma or whole blood |
Brand Name | ZOSBIO | Model Number | 2019-NCoV Neutralizing Antibody |
Certification | CE BfArm | Place of Origin | Henan,China |
High Light | NCoV Neutralizing Antibody Rapid Test |
The kit was used to determine the quality of antibodies and antibodies in human serum, plasma, and whole blood.
Novel crown virus is a new type of corona virus which belongs to the genus Beta. can cause viral pneumonia, the main clinical manifestations are fever, fatigue, dry cough, few patients have a stuffy nose, sore throat, diarrhea. In severe cases, there are respiratory problems and low levels or hypoxia after one week. Severe cases include acute respiratory distress syndrome, septic shock, metabolic acidosis that is difficult to correct, bleeding and coagulation disorders.
The new type of corona virus has various structural proteins: crest protein, E protein, membrane protein, and nuclear protein. Receptor-associated proteins bind domains responsible for identifying receptors on the cell surface. The results revealed a strong interaction between RBD's 2019 ncv spike protein and the human ACE2 receptor that engulfs host cells and pulmonary viruses.
After 2019 years of infection or vaccination, it triggers an immune reaction and produces antibodies in the blood. It secretes anti-viral antibodies that are present in the circulating system of the infected human body for months or years and are rapidly and closely linked to pathogens to protect against viruses. These antibodies are known as neutralizing antibodies. Neutralizing antibodies can check whether people have the ability to protect against viral infections.
The kit includes a test card and a sample buffer solution.
The test card consists of a dry aluminum foil bag, a test strip, and a blister card. The test strip consisted of nitrocellulose absorbent paper, sample film, adhesive sheet and rubber sheet. The T line was coated with ACE2 protein, the C line was coated with antibody, the R line was coated with a control antibody, and the 2019 ncv antigen was marked.
For example, phosphate buffer, sodium oxide, etc.
It is stored for months at temperature.
The shelf life of the aluminum foil bag is one hour after opening the box.
See the product label for more details.
Product expiration date, see label for more details.
Read the instructions carefully before testing. Please recall all chemicals at room temperature before testing and test at room temperature.
Figure for judging test card results:
1. Incorrect result, no reaction on line C, test is invalid and should be repeated.
2. Negative result, line T shows a red bar greater than or equal to control line C and line R.
3. Positive results: The T-line or T-line does not have a red band, but its color appears lower than the control line C and the control line.
1.This kit is a qualitative test and is only used for in vitro diagnostic support.
2. Make sure that the correct number of samples is added for testing. Too large or too small a sample may lead to inaccurate results.
3. Hemolysis, lipidemia, jaundice, and contaminated specimens may affect test results, so avoid these specimens.
4. Test results for this reagent are for clinical use only and should not be used as the sole basis for clinical diagnosis and treatment. The final diagnosis of the disease should be made after a comprehensive evaluation of all clinical and laboratory results.
1. Analysis of specificity
1.1 Cross-reaction: Interference with the following types of antibodies was assessed with the reagents and the results showed that there was no cross-reaction.
SN | Item | Cross reaction | SN | Item | Cross reaction |
1 | Endemic human coronavirus OC43 | No | 10 | Enterovirus | No |
2 | Endemic human coronavirus HKUI | No | 11 | EB virus | No |
3 | Endemic human coronavirus NL63 | No | 12 | Measles virus | No |
4 | Endemic human coronavirus 229E | No | 13 | Human cytomegalovirus | No |
5 | Influenza A virus | No | 14 | Rotavirus | No |
6 | Influenza B virus | No | 15 | Norovirus | No |
7 | Respiratory syncytial virus | No | 16 | Mumps virus | No |
8 | Adenovirus | No | 17 | Varicella-zoster virus | No |
9 | Rhinovirus | No | 18 | Mycoplasma pneumoniae | No |
1.2 Interfering Substances: The following substances were added to the samples at specific concentrations and assessed for their potential interference with the design of the novel coronavirus neutralizing antibody test (2019-nCoV). The results show that different interfering substances will not interfere with the detection results of this reagent.
Interfering substances | Concentration | Interfering substances | Concentration |
Bilirubin | ≤50mg/dL | Triglycerides | ≤15mmol/mL |
Hemoglobin | ≤5g/L | Cholesterol L | ≤500mg/d |
Rheumatoid factor | ≤500IU/mL | Human total IgG | ≤14mg/mL |
Ribavirin | 0.4mg/mL | Fluticasone | 0.5mg/mL |
Oxymetazoline | 10mg/mL | Dexamethasone | 5 mg/mL |
Histamine hydrochloride | 10mg/mL | Triamcinolone acetonide | 5mg /mL |
Tobramycin | 1mg/mL | Levofloxacin | 0.2 mg/mL |
Oseltamivir | 1mg/mL | Azithromycin | 0.1 mg/mL |
Zanamivir | 1mg/mL | Ceftriaxone | 0.4 mg/mL |
Arbidol | 0.5mg/mL | Meropenem | 0.2 mg/mL |
2. Clinical studies: Using the new Coronavirus (2019-nCoV) IgG Antibody Detection Reagent (colloidal gold method) as contrast reagent, 120 positive and 300 negative samples were selected for detection, respectively, and the results were summarized as follows:
2019-nCoV IgG Ab detection reagent (colloidal goldmethod) |
Sum | |||
Positive | Negative | |||
| Positive | 115 | 5 | 120 |
Negtive | 5 | 295 | 300 | |
Sum | 120 | 300 | 420 | |
Sensitivity | 95.83%, (95%CI: 90.62%~98.21%) | |||
Specificity | 98.33%, (95%CI: 96.16%~99.29%) |
1. This product is for in vitro diagnostic use only.
2. This product is disposable and cannot be recycled after use.
3. Before the operation, carefully read the instruction manual and perform the experimental operation in accordance with the reagent instruction manual.
4. Avoid harsh environments (such as environments containing high concentration corrosive gases and dust, such as disinfectant, sodium hypochlorite, acid, alkali, or acetaldehyde). After the experiment is completed, laboratory disinfection should be performed.
5. All specimens and used reagents should be handled as potentially infectious and should be disposed of in accordance with local regulations in case of rejection.
6. Please use the reagent within the expiry date marked on the outer carton, and use the test card as soon as possible after removing it from the aluminum foil bag to prevent moisture.
| Do not re-use |
| Store at 2℃~30℃ |
| Consult instructions for use | | In vitro diagnostic medical device |
| Batch code | | Use-by date |
![]() | Keep dry | | Keep away from sunlight |
| Authorized representative in the European Community | | Manufacturer |
ZHONGXIU SCIENCE AND TECHNOLOGY CO.,LTD
Dingluan industrial zone ,Changyuan City,453400,P.R.CHINA
Tel:+86-371-55016575
Email:zosbio@zosbio.com
Web:www.zosbio.com
SUNGO Europe B.V.
Olympisch Stadion 24, 1076DE Amsterdam, Netherlands
Company Details
Business Type:
Manufacturer,Exporter,Seller
Year Established:
2016
Employee Number:
500~1000
Ecer Certification:
Active Member
Zhongxiu Science And Technology Co.,Ltd., founded in 2016, is located in Dingluan Industrial Zone, Changyuan City, Henan Province. The company covers an area of about 100 acres and the initial investment is about 200 million yuan. The company has a scientific and complete management system, a purifi... Zhongxiu Science And Technology Co.,Ltd., founded in 2016, is located in Dingluan Industrial Zone, Changyuan City, Henan Province. The company covers an area of about 100 acres and the initial investment is about 200 million yuan. The company has a scientific and complete management system, a purifi...
Get in touch with us
Leave a Message, we will call you back quickly!